A European Union (EU)-funded research project InLiveTox project has, claims the European Commission, significantly advanced the capability of in vitro testing of nanoparticles, helping personal care product companies assess whether nano-sized ingredients are safe.
Researchers have especially wanted to focus on the impact of nanoparticle exposure on the gut, cardiovascular system and liver. And they have developed a modular fluidics based in vitro test system, of key importance to the cosmetics sector now that the EU has banned the sale of all cosmetics tested on animals.
An unusually positive Commission note on EU research claimed the project went “beyond expectations, delivering an exciting and innovative technology”, which “could provide a significant competitive advantage…” Brussels added: “It can be used as a testing and research tool in toxicology and pharmacology for any new chemical entity,” saying it could help companies comply with EU REACH chemical controls. Commercial participants in the project included the UK’s laboratory test experts Kirkstall Ltd.